(2S,5R)-5-[(tert-Butoxycarbonyl)aMino]tetrahydro-2H-pyran-2-carboxylic Acid

(2S,5R)-5-[(tert-Butoxycarbonyl)aMino]tetrahydro-2H-pyran-2-carboxylic Acid Suppliers list
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532 18210857532
Email: jkinfo@jkchemical.com
Company Name: Shanghai TaoSu Biochemical Technology Co., Ltd.  
Tel: 021-33632979
Email: info@tsbiochem.com
Company Name: Shanghai AQBioPharma Co., Ltd.  
Tel: 13661411401
Email: yinglv.que@aqbiopharma.com.cn
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com
Company Name: Nanjing Nohon Biological Technology Co., Ltd.  
Tel: 025-85767923 18512596075;
Email: sales@nuoxibio.com
(2S,5R)-5-[(tert-Butoxycarbonyl)aMino]tetrahydro-2H-pyran-2-carboxylic Acid Basic information
Product Name:(2S,5R)-5-[(tert-Butoxycarbonyl)aMino]tetrahydro-2H-pyran-2-carboxylic Acid
Synonyms:(2S,5R)-5-[(tert-Butoxycarbonyl)aMino]tetrahydro-2H-pyran-2-carboxylic Acid;(2S,5R)-5-Boc-aMino-tetrahydropyran-2-carboxylic acid;(2S,5R)-5-{[(tert-butoxy)carbonyl]amino}oxane-2-carboxylic acid;trans-5-(Boc-amino)-tetrahydro-pyran-2-carboxylic acid;L-erythro-Hexonic acid, 2,6-anhydro-3,4,5-trideoxy-5-[[(1,1-dimethylethoxy)carbonyl]amino]-;(2S,5R)-5-(tert-butoxycarbonylamino)tetrahydropyran-2-carboxylic acid
CAS:603130-13-8
MF:C11H19NO5
MW:245.27
EINECS:
Product Categories:Heterocycles, Miscellaneous Reagents
Mol File:603130-13-8.mol
(2S,5R)-5-[(tert-Butoxycarbonyl)aMino]tetrahydro-2H-pyran-2-carboxylic Acid Structure
(2S,5R)-5-[(tert-Butoxycarbonyl)aMino]tetrahydro-2H-pyran-2-carboxylic Acid Chemical Properties
Boiling point 413.9±45.0 °C(Predicted)
density 1.19±0.1 g/cm3(Predicted)
storage temp. 2-8°C
pka3.57±0.40(Predicted)
AppearanceWhite to off-white Solid
Optical Rotation-16.5° (C=0.01 g/ml, CHCL3)
Safety Information
MSDS Information
(2S,5R)-5-[(tert-Butoxycarbonyl)aMino]tetrahydro-2H-pyran-2-carboxylic Acid Usage And Synthesis
Uses(2S,5R)-5-[(tert-Butoxycarbonyl)amino]tetrahydro-2H-pyran-2-carboxylic Acid is aids in the synthesis of novel tetrahydropyran-based, topoisomerase inhibitors with anti-gram-positive activity. Also used in the synthesis of novel tetrahydropyran-based dipeptide isoster compounds.
Synthesis
1,5-Anhydro-2,3,4-trideoxy-2-[[(1,1-diMethylethoxy)carbonyl]aMino]-D-erythrohexitol

603130-12-7

(2S,5R)-5-[(tert-Butoxycarbonyl)aMino]tetrahydro-2H-pyran-2-carboxylic Acid

603130-13-8

General procedure for the synthesis of (2S,5R)-5-((tert-butoxycarbonyl)amino)tetrahydro-2H-pyran-2-carboxylic acid from tert-butyl (3R,6S)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)carbamate: tert-butyl (3R,6S)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)carbamate was added to the reactor (1700 g 1 eq. for preparation see Kriek et al. Eur. J. Org. Chem. 2003, 13, 2418-2427), NaHCO3 (1241 g, 2 eq.), KBr (87 g, 0.1 eq.), TEMPO (17.6 g, 0.015 eq.), Aliquat 336 (17 mL, 0.005 eq. ) and iPrOAc (17 L). The suspension was cooled to 0°C and 10% NaOCl solution (10.2 L, 2.33 eq.) was added slowly, controlling the internal temperature below 5°C. The reaction mixture was stirred at 10°C for 90 min and complete consumption of the raw materials was confirmed by TLC (ninhydrin staining assay). A 40% NaHSO3 solution (1.5 L) was added at 12°C to quench the reaction, followed by the addition of 25% HCl (2.5 L) at 15°C. The mixture was warmed up to 20°C and the aqueous and organic phases were separated. The aqueous phase was extracted with iPrOAc (8.5 L) and the organic phase was combined and washed with deionized water (15 L). The organic phase was concentrated at a jacket temperature of 100°C and under reduced pressure to remove 18 L of solvent. The residue was cooled to 65 °C, heptane (14 L) was added and the resulting suspension was cooled to -6 °C and filtered. The product was dried over a rotary evaporator (20 L) to afford (2S,5R)-5-((tert-butoxycarbonyl)amino)tetrahydro-2H-pyran-2-carboxylic acid as a white solid (1406 g, 78% yield).1H-NMR (d6-DMSO): δ=12.64 (m, 1H), 6.85 (m, 1H), 3.84 (m, 1H), 3.76 (m, 1H), 3.32 (m, 1H), 3.01 (t, J=10.5 Hz, 1H), 1.92 (m, 2H), 1.53 (m, 2H), 1.39 (s, 9H).GC-MS: tR=3.49 min; [M+1]+=246.

References[1] Patent: WO2012/164498, 2012, A1. Location in patent: Page/Page column 31
[2] European Journal of Organic Chemistry, 2003, # 13, p. 2418 - 2427
[3] Journal of Medicinal Chemistry, 2013, vol. 56, # 18, p. 7396 - 7415
(2S,5R)-5-[(tert-Butoxycarbonyl)aMino]tetrahydro-2H-pyran-2-carboxylic Acid Preparation Products And Raw materials
Raw materials1,5-Anhydro-2,3,4-trideoxy-2-[[(1,1-diMethylethoxy)carbonyl]aMino]-D-erythrohexitol-->Potassium bromide-->Methyl trioctyl ammonium chloride-->TEMPO-->Sodium bicarbonate-->Isopropyl acetate-->Sodium hypochlorite
Tag:(2S,5R)-5-[(tert-Butoxycarbonyl)aMino]tetrahydro-2H-pyran-2-carboxylic Acid(603130-13-8) Related Product Information
1,5-Anhydro-2,3,4-trideoxy-2-[[(1,1-diMethylethoxy)carbonyl]aMino]-D-erythrohexitol 2,6-Anhydro-3,4,5-trideoxy-5-[[(1,1-diMethylethoxy)carbonyl]aMino]-D-threo-hexonic Acid 5-((tert-Butoxycarbonyl)aMino)tetrahydro-2H-pyran-2-carboxylic Acid NROSRTMHTJHLLE-YUMQZZPRSA-N D-erythro-Hexonic acid, 2,6-anhydro-3,4,5-trideoxy-5-[[(1,1-dimethylethoxy)carbonyl]amino]- 5-(((Benzyloxy)carbonyl)amino)tetrahydro-2H-pyran-2-carboxylic acid